Skip to Content

CTI 103 (Diclofenac sodium delayed release 75 mg)

Pill imprint CTI 103 has been identified as Diclofenac sodium delayed release 75 mg.

Diclofenac is used in the treatment of back pain; sciatica; pain; osteoarthritis; frozen shoulder (and more), and belongs to the drug class nonsteroidal anti-inflammatory agents. There is positive evidence of human fetal risk during pregnancy. Diclofenac 75 mg is not a controlled substance under the Controlled Substance Act (CSA).

Diclofenac sodium delayed release 75 mg CTI 103
Discount Card Promo
Diclofenac sodium delayed release
Imprint:
CTI 103
Strength:
75 mg
Color:
White
Shape:
Round
Availability:
Prescription only
Drug Class:
Nonsteroidal anti-inflammatory agents
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Manufacturer:
Carlsbad Technology, Inc.
National Drug Code (NDC):
61442-0103
Inactive Ingredients:
ferrosoferric oxide
hypromelloses
lactose monohydrate
magnesium stearate
methacrylic acid - methyl methacrylate copolymer (1:1)
microcrystalline cellulose
shellac
povidone
sodium starch glycolate type A potato
magnesium silicate
titanium dioxide
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
42291-0231 AvKare, Inc.

Note: Inactive ingredients may vary.

View Details Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide